Camrelizumab Plus Apatinib Combined with Gemcitabine and Oxaliplatin (GEMOX) as First-Line Treatment for Advanced Biliary Tract Cancer (BTC): A Biomarker Exploratory Phase II Trial

oxaliplatin - Generic mfg.

AiTan (rivoceranib) - Elevar Therapeutics

gemcitabine - Generic mfg.

AiRuiKa (camrelizumab) - Elevar Therapeutics

Min Dong; Lijuan Lu; Qu Lin; Zexiao Lin; Xing Li; Feifei Xu; Donghao Wu; Jingyun Wen; Miaokun Ma; Li Wei; Jie Chen; Xiangyuan Wu

Jul 17, 2026